April 23, 2025 - 16:38
The FDA has halted its quality control program that tests milk but promised to protect the safety of the pasteurized milk supply. This decision comes in the wake of budget cuts imposed by the Department of Health and Human Services, which have raised concerns about the potential impact on food safety standards.
The agency stated that while the testing program is paused, it remains committed to ensuring that the milk available to consumers is safe and meets quality standards. The FDA plans to transfer laboratory operations to streamline processes and potentially reduce costs, although specific details on this transition have not yet been disclosed.
This suspension has sparked discussions among dairy farmers, processors, and public health advocates about the implications for consumer safety and industry standards. Many stakeholders are urging the FDA to reconsider the suspension and to explore alternative funding avenues to maintain rigorous testing protocols. The situation is evolving, and the FDA's next steps will be closely monitored by those invested in food safety and public health.
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...